Declining Costs Boost Allure of GNOM Genomics ETF

Declining costs are viewed as one of the biggest factors driving the genomics and data suggest those costs continue falling, a scenario that could benefit ETFs, such as the Global X Genomics & Biotechnology ETF (Nasdaq: GNOM). GNOM tracks the Solactive Genomics Index and “seeks to invest in...